Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte Secures Medicare Coverage for Genomic Thyroid Cancer Test

NEW YORK (GenomeWeb News) — Veracyte said today that Medicare contractor Palmetto GBA has agreed to cover its Afirma Gene Expression Classifier for use in thyroid nodule diagnosis.

The coverage decision means that Veracyte's genomic test "is now accessible to 40 million Medicare patients nationwide," the company said.

The Afirma test is intended to determine whether inconclusive thyroid nodule results are benign or suspicious for cancer.

The company said that around 450,000 thyroid nodule fine-needle aspiration tests are performed each year in the US, but the results are ambiguous in up to 30 percent of cases. Current guidelines recommend surgery for most of these ambiguous cases, even though inconclusive FNA results carry only a 20 percent to 30 percent chance of malignancy.

Bonnie Anderson, co-founder and CEO of Veracyte, said in a statement that Palmetto's decision "will help Medicare patients with inconclusive results access our Afirma Gene Expression Classifier, enabling them to potentially avoid surgery, while also saving money for the Medicare program."

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.